Results 121 to 130 of about 149 (149)

Pancreatic Enzyme Replacement Therapy Improves Exclusive Enteral Nutrition Related Diarrhea in Crohn's Disease: A Prospective Randomized Trial

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background & Aims Previous results showed that combined treatment of biologics and exclusive enteral nutrition (EEN) brought moderate‐to‐severe Crohn's disease patients significant improvements in clinical and endoscopic outcomes. Despite its essential role and favorable safety profile, EEN in the treatment of adult Crohn's disease is ...
Jian Kang, Jing Wang, Juan Su, Wei Wang, Yueyue Lu, Zhishun Tang, Liping Zou, Anning Yin, Jiao Li, Haixia Ren, Qian Zhou, Huipeng Wan, Ping An   +12 more
wiley   +1 more source

Pediatric Autoimmune Pancreatitis: Clinical Findings and Outcomes in Sweden

United European Gastroenterology Journal, EarlyView.
ABSTRACT Introduction Pediatric autoimmune pancreatitis (AIP) is a rare form of pancreatitis in children with poorly understood pathophysiology. It is a recognized risk factor for chronic pancreatitis in approximately 4% of pediatric cases. This study aims to describe the demographics, clinical characteristics, and outcomes of a large Swedish cohort of
Miroslav Vujasinovic, Fredrik Lindgren, Nikolaos Kartalis, Raffaella Pozzi Mucelli, Dawid Rutkowski, Alexander Waldthaler, Poya Ghorbani, Carlos Fernández Moro, Thomas Casswall, J.‐Matthias Löhr   +9 more
wiley   +1 more source

Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches

PROTEOMICS, EarlyView.
Paul Perco, Matthias Ley, Kinga Kęska‐Izworska, Dorota Wojenska, Enrico Bono, Samuel M. Walter, Lucas Fillinger, Klaus Kratochwill   +7 more
wiley   +1 more source

Dissecting Microscopic Colitis Immunopathophysiology: Insights From Basic Research

United European Gastroenterology Journal, EarlyView.
ABSTRACT Microscopic colitis is an inflammatory bowel disease (IBD) comprising two clinically undiscernible entities: collagenous colitis and lymphocytic colitis. Collagenous colitis associates with HLA genes and displays a Th1/Tc1–Th17/Tc17 profile with pericryptal myofibroblast activity, water malabsorption and secondary fluid loss due to altered ...
Andreas Münch, Celia Escudero‐Hernández   +1 more
wiley   +1 more source

Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background Chronic pancreatitis is a risk factor for pancreatic cancer. Autoimmune pancreatitis is a unique form of chronic pancreatitis that is primarily characterized by its immune mediate etiology, clinically resembling pancreatic cancer, yet uniquely responsive to steroid treatment.
Vladyslav Dovhalyuk, Fan Yang, Sara Nikolic, Miroslav Vujasinovic, J.‐Matthias Löhr, Daniel Globisch   +5 more
wiley   +1 more source

The chemistry of non-steroidal anti-inflammatory agents [PDF]

Pure and Applied Chemistry, 1969
Abstract
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics of Non‐Steroidal Anti‐Inflammatory Agents

Australian and New Zealand Journal of Medicine, 1978
Summary: Pharmacokinetics of non‐steroidal anti‐inflammatory agents. G. D. Champion and G. G. Graham, Aust. N.Z. J. Med., 1978, 8, Suppl. 1, pp 94–100. The non‐steroidal anti‐inflammatory drugs (NSAID) are well absorbed from the gastrointestinal tract. The only known exception is aspirin.
Garry G. Graham, G. D. Champion
openaire   +3 more sources

The regulatory control of non-steroidal anti-inflammatory agents

European Journal of Clinical Pharmacology, 1981
The number of marketed non-steroidal anti-inflammatory agents varies widely from one European country to another, partly as a consequence of differing regulatory policies. During a four-year period, nine of 18 applications to market such drugs in the Netherlands failed; the remaining nine compounds were all licenced; in all, 22 single drug entities of ...
I. Lunde, M. N. G. Dukes
openaire   +3 more sources

Non Steroidal Anti-Inflammatory and Anti-Allergy Agents

Current Medicinal Chemistry, 2002
Non steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used for inflammation therapy. The major drawback in using the NSAIDs is in their tendency to cause gastrointestinal toxicity. Since the roles of arachidonic acid (A.A) metabolites, as leukotrienes (Lts), prostaglandins (PGs) and thromboxanes (TXA(2)) as mediators of the ...
Christos Kontogiorgis, Dimitra Hadjipavlou-Litina   +1 more
openaire   +2 more sources

Comparative toxicity of non-steroidal anti-inflammatory agents

Pharmacology & Therapeutics, 1994
Comparative toxicity of non-steroidal anti-inflammatory drugs was assessed using the Stanford Toxicity Index consisting of weighted symptoms, laboratory abnormalities and hospitalizations in 2976 consecutively enrolled rheumatoid arthritis patients from eight data bank centers with 27,936 patient-years of observation.
Dena R. Ramey, Dianne Morfeld, Gurkirpal Singh, James F. Fries   +3 more
openaire   +3 more sources